Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_assertion type Assertion NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_head.
- NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_assertion description "[We investigated genetically affected leukemic cells in FIP1L1-PDGFRA+ chronic eosinophilic leukemia (CEL) and in BCR-ABL1+ chronic myeloid leukemia (CML), two myeloproliferative disorders responsive to imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_provenance.
- NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_assertion evidence source_evidence_literature NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_provenance.
- NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_assertion SIO_000772 17215855 NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_provenance.
- NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_assertion wasDerivedFrom befree-20140225 NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_provenance.
- NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_assertion wasGeneratedBy ECO_0000203 NP801216.RA-W7IZBWU67MO887Rhfh2V75kCB_xyyrgKPfUmbLmvFo130_provenance.